Neuronetics, Inc. (STIM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 38,108 | 31,975 | 18,530 | 16,450 |
| Cost of revenues | 20,350 | 16,237 | 4,529 | 4,271 |
| Gross profit | 17,758 | 15,738 | 14,001 | 12,179 |
| Sales and marketing | 11,868 | 11,999 | 11,877 | 12,303 |
| Research and development | 1,798 | 1,616 | 2,416 | 2,235 |
| General and administrative | 12,150 | 13,137 | 7,436 | 6,148 |
| Total operating expenses | 25,816 | 26,752 | 21,729 | 20,686 |
| Loss from operations | -8,058 | -11,014 | -7,728 | -8,507 |
| Interest expense | 1,969 | 1,922 | 1,725 | 1,978 |
| Other income, net | 188 | 247 | 539 | 653 |
| Net loss | -9,839 | -12,689 | - | - |
| Less net income attributable to non-controlling interest | 281 | -14 | - | - |
| Gains losses on extinguishment of debt | - | - | -4,427 | - |
| Net loss attributable to neuronetics stockholders' | -10,120 | -12,675 | -13,341 | -9,832 |
| Earnings per share, basic | -0.15 | -0.21 | -0.44 | -0.33 |
| Earnings per share, diluted | -0.15 | -0.21 | -0.44 | -0.33 |
| Weighted average number of shares outstanding, basic | 66,180,000 | 61,465,000 | 30,267,000 | 30,052,000 |
| Weighted average number of shares outstanding, diluted | 66,180,000 | 61,465,000 | 30,267,000 | 30,052,000 |